成人糖尿病患者心血管疾病风险等危状态的识别与预测因素
该研究汇总美国四个队列共27730名成人,按基线糖尿病和心血管疾病状态分组,比较糖尿病不伴CVD者与无糖尿病但伴CVD者的CVD风险。结果显示约19.1%的无CVD糖尿病患者其CVD风险等同于心梗病史者,HbA1c≥7%、糖尿病病程≥10年及使用降糖药是预测因素。
要点
- 约五分之一无CVD的糖尿病患者心血管风险等同于已有CVD者。
- HbA1c≥7%、糖尿病病程≥10年或使用降糖药提示风险等危。
- 女性、白人、年轻或甘油三酯/ hs-CRP高、肾功能下降者风险等危更明显。
核心结论
- 约19.1%的无CVD糖尿病患者其CVD风险等同于已有CVD者。
- HbA1c≥7%、糖尿病病程≥10年及使用降糖药是CVD风险等危的预测因素。
研究设计与样本
- 汇总美国ARIC、JHS、MESA和FHS-Offspring四个队列,共27730名受试者(平均年龄58.5岁,44.6%男性)。
- 按基线糖尿病/CVD状态分组,比较DM+/CVD-与DM-/CVD+组的CVD风险,并分析糖尿病严重程度及亚组。
主要发现
- CVD发生率(每1000人年):DM-/CVD-为16.5,DM+/CVD-为33.4,DM-/CVD+为43.2,DM+/CVD+为71.4。
- 与DM-/CVD+相比,HbA1c≥7%、糖尿病病程≥10年或使用降糖药者CVD风险相似或更高。
- DM+/CVD- vs DM-/CVD+的风险比(95%CI):女性0.96(0.86-1.07),白人0.97(0.88-1.07),年龄<55岁0.96(0.82-1.13),甘油三酯≥2.26 mmol/L者1.18(0.98-1.41),hs-CRP≥2 mg/L者0.93(0.85-1.02),eGFR<60 mL/min/1.73 m2者1.00(0.89-1.13)。
- DM+/CVD-组中19.1%存在CVD风险等危,其风险评分较低但实际CVD风险较高。
关键数值与推荐
- HbA1c≥7%、糖尿病病程≥10年或使用降糖药可作为识别CVD风险等危的预测指标。
- 女性、白人、年龄<55岁、甘油三酯≥2.26 mmol/L、hs-CRP≥2 mg/L或eGFR<60 mL/min/1.73 m2的糖尿病患者CVD风险等危更明显。
临床怎么用
- 对无CVD的糖尿病患者应评估HbA1c、病程及用药情况,识别CVD风险等危者。
- 关注女性、白人、年轻及合并高甘油三酯、高hs-CRP或肾功能下降的糖尿病患者。
局限性
- 研究为观察性队列汇总分析,可能存在残余混杂。
- 风险等危算法需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We examined diabetes as a cardiovascular disease (CVD) risk equivalent based on diabetes severity and other CVD risk factors. RESEARCH DESIGN AND METHODS: We pooled four U.S. cohorts (Atherosclerosis Risk in Communities [ARIC], Jackson Heart Study [JHS], Multi-Ethnic Study of Atherosclerosis [MESA], and Framingham Heart Study Offspring Cohort [FHS-Offspring]) and classified subjects into groups by baseline diabetes/CVD status (positive or negative). CVD risks of the diabetes mellitus (DM)+/CVD- group versus DM-/CVD+ group were examined by diabetes severity and in subgroups of other CVD risk factors. We developed an algorithm to identify subjects with CVD risk equivalent diabetes by comparing the relative CVD risk of being DM+/CVD- versus DM-/CVD+. RESULTS: The pooled cohort included 27,730 subjects (mean age 58.5 years, 44.6% male). CVD rates per 1,000 person-years were 16.5, 33.4, 43.2, and 71.4 among those DM-/CVD-, DM+/CVD-, DM-/CVD+, and DM+/CVD+, respectively. Compared with those DM-/CVD+, CVD risks were similar or higher for those with HbA1c ≥ 7%, diabetes duration ≥10 years, or diabetes medication use, while those with less severe diabetes had lower risks. Hazard ratios (95% CI) for DM+/CVD- vs. DM-/CVD+ were 0.96 (95% CI 0.86-1.07), 0.97 (0.88-1.07), 0.96 (0.82-1.13), 1.18 (0.98-1.41), 0.93 (0.85-1.02), and 1.00 (0.89-1.13) among women and those of White race, age <55 years, and with triglycerides ≥2.26 mmol/L, hs-CRP ≥2 mg/L, and estimated glomerular filtration rate <60 mL/min/1.73 m2, respectively. In the DM+/CVD- group, 19.1% had CVD risk equivalent diabetes with a lower risk score but a higher observed CVD risk. CONCLUSIONS: Diabetes is a CVD risk equivalent in one-fifth of CVD-free adults living with diabetes. High HbA1c, long diabetes duration, and diabetes medication use were predictors of CVD risk equivalence. Diabetes is a CVD risk equivalent for women, white people, and those of younger age or with higher triglycerides or hs-CRP or reduced kidney function.
引用
- Zhao Y, Malik S, Budoff MJ, et al. Identification and Predictors for Cardiovascular Disease Risk Equivalents Among Adults With Diabetes. Diabetes Care. 2021. PMID: 34380703. doi:10.2337/dc21-0431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。